483
Baxter Healthcare SABaxter Healthcare SA – FDA 483, Dec 13, 2024
Record Details
An FDA inspection of Baxter Healthcare SA in Singapore revealed significant deficiencies in quality control and manufacturing processes. The firm failed to thoroughly investigate unexplained discrepancies, product complaints, and out-of-specification results. Additionally, inadequate laboratory controls for environmental monitoring and microbial identification, along with a failure to follow written procedures for component storage and handling, were observed.
View Company Profile
ID · 375ca287-ee65-4b58-bd8b-69db4c9328fb
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.